At the KBW Insurance Conference in September 2026, Aflac’s Chief Financial Officer Max Brodén outlined the company’s strategic priorities, including capital deployment, operational efficiency through artificial intelligence, and adjustments to its Japan portfolio amid a historically steep yield environment. The firm, with a market cap of $57.22 billion and a P/E ratio of 12.26, reported a 42-year streak of dividend increases and a dividend yield of 2.13%. Return on equity stood at 17%, while free cash flow ranged between $2.5 billion and $3 billion annually. Shares closed at $117.55 on November 9, up 0.46% from the prior day’s close.
In Japan, Aflac repositioned about 5% of its portfolio in the second quarter—a significant move given the steepest yield curve in over 25 years. The shift contributed roughly $50 million in incremental annual net investment income, while reducing unrealized losses on the Japanese Government Bond portfolio. Third-sector sales grew 24% in 2025, driven by Miraito, a cancer insurance product, though growth is expected to slow as comparisons tighten. Anshin Palette, a refreshed medical product launched in late 2024, showed strong year-over-year growth, though absolute volumes remain modest. Benefit ratios in Japan tracked toward the upper end of the 60%–63% target range, driven by lapsation pressures from younger policies, while expense ratios trended toward the lower end of the 20%–23% range.
Brodén emphasized the yield curve’s impact on life insurance as a savings vehicle, noting it has never been more attractive in decades. The company also raised its internal reinsurance limit with Japanese regulators from 10% to 30%, reflecting regulatory flexibility and risk management adjustments. In the U.S., Aflac targets a 3%–6% compound annual growth rate in premiums from 2025 to 2027, with persistency improvements of 20–30 basis points annually. Pre-tax margins are expected to remain in the 17%–20% range.
Regarding AI, Brodén acknowledged its potential for operational efficiency but remained cautious about expense savings. The company’s investment portfolio includes about 1% in data centers and hyperscalers, though it remains a minor component. Aflac’s reinsurance subsidiary, Aflac Re, holds a double-A rating and focuses on mortality, longevity, and spread risk. Newer U.S. lines, including group life, disability, dental, vision, and direct-to-consumer offerings, are expected to reach meaningful scale in 2 years to 3 years.
The discussion underscored Aflac’s dual focus on capital preservation and growth, particularly in Japan’s evolving market dynamics, while positioning itself for long-term operational and financial resilience.
